TY  - JOUR
AU  - Pine, Sharon R.
AU  - Ryan, Bríd M.
PY  - 2018
TI  - Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach
JF  - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1
Y2  - 2018
KW  - 
N2  - In the last three decades, 5-year relative survival rates for lung cancer improved slightly, from 14.3%, 15.5%, and 18.4% (1). One of the reasons for these dismal survival rates is that most patients present with advanced-stage disease, a time during which systemic therapies are unlikely to be curative.
UR  - https://tlcr.amegroups.org/article/view/23934